» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 127 | NO. 90 | Tuesday, May 8, 2012

Tennessee Will Get $1.95 Million From Drug Agreement

AP

Print | Front Page | Email this story | Comments ()

NASHVILLE (AP) – Tennessee will receive $1.95 million coming from a multistate settlement between a giant pharmaceutical company accused of deceptively marketing the anti-seizure drug Depakote.

The state's cut was part of a $100 million agreement between 45 states and the District of Columbia and Abbott Laboratories. The agreement is the largest consumer protection-based pharmaceutical settlement ever reached.

The states accused the pharmaceutical company of engaging in deceptive marketing practices when it marketed Depakote for off-label uses. Depakote has been approved for the treatment of seizures, migraine headaches and mania associated with bipolar disorder. The states said the company marketed the drug to treat medical issues where the drug has not been approved, such as schizophrenia, agitated dementia and autism.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 87 87 7,836
MORTGAGES 108 108 9,307
FORECLOSURE NOTICES 8 8 1,366
BUILDING PERMITS 130 130 16,737
BANKRUPTCIES 55 55 5,461
BUSINESS LICENSES 32 32 2,980
UTILITY CONNECTIONS 47 47 3,297
MARRIAGE LICENSES 37 37 1,725

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.